September 26, 2016 9:44 PM ET

Biotechnology

Company Overview of Alnylam Pharmaceuticals, Inc.

Executive Profile

Phillip A. Sharp Ph.D.

Co-Founder, Director, Member of the Scientific Advisory Board, Chairman of Science & Technology Committee and Member of Nominating & Corporate Governance Committee, Alnylam Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 10 Board Members in 10 different organizations across 9 different industries.

See Board Relationships
71$948,385

Background

Dr. Phillip A. Sharp, also known as Phil, Ph.D., Co-Founded Alnylam Pharmaceuticals, Inc. in 2002. Dr. Sharp serves as the President of American Association for the Advancement of Science. He Co-founded Biogen Idec Inc. in 1978. He co-founded Magen BioSciences, Inc. (now known as PPD Dermatology, Inc.) in 2006. He serves as the Chairman of Scientific Advisory Board of Fidelity Biosciences. He served as Co-Chairman of Scientific Strategy and Advisory Group of Alnylam ...

Corporate Headquarters

300 Third Street
Cambridge, Massachusetts 02142

United States

Phone: 617-551-8200
Fax: 617-551-8101

Board Members Memberships

Director
Director
Director and Member of Strategic Advisory Board
2002-Present
Co-Founder, Director, Member of the Scientific Advisory Board, Chairman of Science & Technology Committee and Member of Nominating & Corporate Governance Committee
2012-Present
Director, Member of Scientific Advisory Board and Chairman of Compensation Committee

Education

PhD
University of Illinois-Urbana-Champaign
BA
Union College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$90,000
Total Calculated Compensation$948,385
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Stanley T. Crooke M.D., Ph.D.Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee
Ionis Pharmaceuticals, Inc.
$1.5M
Edward M. Kaye M.D., Ph.D.Chief Executive Officer, President, Chief Medical Officer and Director
Sarepta Therapeutics, Inc.
$494.6K
Mark Joseph Murray Ph.D.Chief Executive Officer, President and Executive Director
Arbutus Biopharma Corporation
$954.9K
Paul C. Grint M.D.Chief Executive Officer, President and Director
Regulus Therapeutics Inc.
$446.5K
Douglas M. Fambrough III, Ph.D.Co-Founder, Chief Executive Officer, President and Director
Dicerna Pharmaceuticals, Inc.
$490.0K
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Alnylam Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.